Zicam Cold Remedy Medicated Fruit Drops gives cold-fighters another choice
BRIDGEWATER, N.J. — Zicam on Tuesday announced the national launch of Zicam Cold Remedy Medicated Fruit Drops, offered in an assortment of fruity flavors.
“Coming down with a cold is an unpleasant experience; in addition to dealing with symptoms, we can also feel more isolated and lonely,” stated M'lou Walker, CEO Zicam. “At Zicam, we are always looking for ways to show our consumers that we are there for them. We are passionate about helping people get back to feeling better, so they can enjoy time with their family and friends. With our new Medicated Fruit Drops, we hope to bring a delectable mix of flavor into cold shortening, while making a difference in people’s lives.”
Zicam Cold Remedy Medicated Fruit drops are non-drowsy and non-habit forming. The soft assorted fruit drops come in a mix of three distinct flavors: orange, lemon and cherry, and contain pectin, a premium gelling agent that helps prevent the product from melting and sticking together. Each container holds 25 fruit drops, and can be found at major retailers nationwide.
"We recognize that consumers are looking for more choices in form and flavor when in the cold aisle, so we are always innovating new ways to shorten colds,” said Lori Norian, vice president marketing at Zicam. "We care about those using our products and with our new Medicated Fruit Drops we aimed to create another delicious, yet unique, way to get better faster. Early results are showing that consumers agree.”
GSK Consumer Healthcare, CVS Health join forces to support ALA stop-smoking initiative
WARREN, N.J. — In support of Lung Cancer Awareness Month, GSK Consumer Healthcare, CVS Health and the American Lung Association's Lung Force are joining together to help people quit smoking and raise awareness of lung cancer. For every box of Nicorette or NicoDerm CQ purchased at a CVS Pharmacy throughout November, GSK Consumer Healthcare will donate $1 to the American Lung Association's Lung Force (up to $100,000).
"CVS Health is proud to partner with the American Lung Association and GSK to fight against lung cancer and provide people with the help they need to quit smoking," stated Eileen Howard Boone, senior vice president, corporate social responsibility and philanthropy, CVS Health. "We know it can take seven or more tries to quit and as a company that is committed to helping people on their path to better health, we want to provide the support needed and increase awareness of this deadly disease."
"GSK Consumer Healthcare is proud to partner with CVS Health this Lung Cancer Awareness Month to support the American Lung Association and to further our commitment to helping smokers create a successful quit plan," added James Masterson, marketing director, Smokers' Health, GSK Consumer Healthcare. "We know quitting smoking is not easy, but we encourage smokers to take the first step towards a smoke-free life with the help of Nicorette and NicoDerm CQ and the proper support."
The partnership aims to educate smokers on the importance of quitting smoking with the help of nicotine replacement therapy and behavioral support. Research shows that quitting cold turkey doesn't work for many smokers – in fact, only 3% to 5% of smokers who attempt to quit without support are successful.
CVS MinuteClinic offers a smoking cessation program, which includes a 1-on-1 consultation with a practitioner, an individualized smoking cessation plan and education based on a patient's needs and goals, as well as ongoing coaching and support in their efforts to quit smoking.
"Lung cancer is the leading cause of cancer deaths among women and men in the United States, and quitting smoking is the best way to reduce your risk of lung cancer," commented Harold Wimmer, national president and CEO American Lung Association. "We are thankful to GSK Consumer Healthcare for its support of our Lung Force initiative that is leading the way for better lung cancer prevention, early detection and treatments."
Americans should be preparing for a doozy of a flu season, professor says
BIRMINGHAM, Ala. — Be prepared for a virulent flu season this year, suggested Kevin Harrod, professor in the UAB Department of Anesthesiology and Perioperative Medicine. Recent reports show that Australia has seen its worst flu season on record. And Harrod says what happens in the southern hemisphere is usually indicative of what type of flu season will occur in the northern hemisphere.
“These data tell us that we should see a worse than average flu season,” Harrod said. “But, with all things influenza, there’s a lot we don’t know.”
Harrod says this year’s vaccines are combating the H3N2 strain and B strains of influenza. He added that H3N2 viruses cause worse disease in the elderly and young children, and that they are associated with a high hospitalization rate.
With all the knowledge and scientific research about influenza, Harrod says it is extremely difficult to perfectly forecast which strains are used to create vaccines.
“There are always a few strains circulating that aren’t predominant, but can become predominant — especially in populations of high immunization,” he said. “So, it’s difficult for public health officials to predict which strains will circulate. For that reason, not every vaccine is a perfect match.